NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Vivos Therapeutics Inc (NASDAQ: VVOS)
VVOS Technical Analysis
5
As on 9th Jun 2023 VVOS STOCK Price closed @ 0.42 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.67 & Strong Sell for SHORT-TERM with Stoploss of 2.58 we also expect STOCK to react on Following IMPORTANT LEVELS. |
VVOSSTOCK Price
Open | 0.47 | Change | Price | % |
High | 0.48 | 1 Day | -0.05 | -10.64 |
Low | 0.42 | 1 Week | 0.02 | 5.00 |
Close | 0.42 | 1 Month | 0.10 | 31.25 |
Volume | 233828 | 1 Year | -2.14 | -83.59 |
52 Week High 3.63 | 52 Week Low 0.31 |
NASDAQ USA Most Active Stocks
TSLA | 244.40 | 4.06% |
TTOO | 0.07 | -12.50% |
SOFI | 8.18 | 0.74% |
FFIE | 0.33 | 6.45% |
PONO | 1.72 | 2.38% |
AMD | 124.92 | 3.20% |
IDEX | 0.06 | 0.00% |
NKLA | 0.70 | 14.75% |
AMZN | 123.43 | -0.66% |
AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
VVOS Daily Charts |
VVOS Intraday Charts |
Whats New @ Bazaartrend |
VVOS Free Analysis |
|
VVOS Important Levels Intraday
RESISTANCE | 0.54 |
RESISTANCE | 0.50 |
RESISTANCE | 0.48 |
RESISTANCE | 0.45 |
SUPPORT | 0.39 |
SUPPORT | 0.36 |
SUPPORT | 0.34 |
SUPPORT | 0.30 |
VVOS Forecast April 2024
4th UP Forecast | 4.02 |
3rd UP Forecast | 2.87 |
2nd UP Forecast | 2.15 |
1st UP Forecast | 1.44 |
1st DOWN Forecast | -0.6 |
2nd DOWN Forecast | -1.31 |
3rd DOWN Forecast | -2.03 |
4th DOWN Forecast | -3.18 |
VVOS Weekly Forecast
4th UP Forecast | 1.58 |
3rd UP Forecast | 1.21 |
2nd UP Forecast | 0.98 |
1st UP Forecast | 0.75 |
1st DOWN Forecast | 0.09 |
2nd DOWN Forecast | -0.14 |
3rd DOWN Forecast | -0.37 |
4th DOWN Forecast | -0.74 |
VVOS Forecast2024
4th UP Forecast | 6.95 |
3rd UP Forecast | 4.86 |
2nd UP Forecast | 3.56 |
1st UP Forecast | 2.27 |
1st DOWN Forecast | -1.43 |
2nd DOWN Forecast | -2.72 |
3rd DOWN Forecast | -4.02 |
4th DOWN Forecast | -6.11 |
Vivos Therapeutics Inc ( NASDAQ USA Symbol : VVOS )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
VVOS Other Details
Segment | EQ | |
Market Capital | 82123560.00 | |
Sector | Healthcare | |
Industry | Medical Devices | |
Offical website | > echo $website ; ?> |
VVOS Address
VVOS Latest News
VVOS Business Profile
Vivos Therapeutics, Inc., a medical technology company, engages in the development and commercialization of treatment alternatives for patients with sleep disordered breathing, such as mild-to-moderate obstructive sleep apnea (OSA). Its treatment, the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of mild to moderate OSA. Vivos Therapeutics also offers VivoScore, a comprehensive home sleep apnea test. The company markets and sells its Vivos System to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Highlands Ranch, Colorado. Address: 9137 South Ridgeline Boulevard, Highlands Ranch, CO, United States, 80129
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service